8 Myalgic Encephalomyelitis Clinical Trials in Austin, MN (2026)

Q: How do I join a clinical trial in Austin?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Austin research site will contact you.

Recruiting Myalgic Encephalomyelitis Studies in Austin

NCT05458219Recruiting

A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

This is a Phase Ia/Ib, multicenter, open-label, first-in-human study to evaluate the safety, tolerability, PK, and efficacy of IBI343 in participants with locally advanced unresectable or metastatic s...

Austin, MN470 participantsInnovent Biologics (Suzhou) Co. Ltd.

View Study Details

NCT05267626Recruiting

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

This is a first in human, open-label, multi-center Phase 1 / 2 study to evaluate the safety, tolerability, and initial efficacy of AU-007 in patients with advanced solid tumors. AU-007 will be adminis...

Austin, MN159 participantsAulos Bioscience, Inc.

View Study Details

NCT06270706Recruiting

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

This is a Phase 1a/1b, dose-escalation/expansion, consecutive-cohort, open-label study to evaluate the safety, tolerability, PK, PD, and preliminary evidence of antitumor activity of PLN-101095 in com...

Austin, MN124 participantsPliant Therapeutics, Inc.

View Study Details

NCT06566079Recruiting

Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid Tumors

This is a Phase 1, open-label, multicenter, FIH study to evaluate the safety, tolerability, recommended Phase 2 dose (RP2D), PK/PD, and preliminary anti-tumor activity of ISM6331 in participants with ...

Austin, MN100 participantsInSilico Medicine Hong Kong Limited

View Study Details

NCT06585462Recruiting

Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity

The primary objective of this study is to assess the safety and tolerability of AMG 513 after single and multiple doses....

Austin, MN80 participantsAmgen

View Study Details

NCT07157254Recruiting

A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)

The main goal of the study is to evaluate the safety and efficacy of GTX-102 in participants with Angelman syndrome....

Austin, MN60 participantsUltragenyx Pharmaceutical Inc

View Study Details

NCT07370311Recruiting

A Culturally Adapted Decision Aid Intervention to Support Chinese American Dementia Caregivers in Feeding-Related Decisions

Family caregivers of people with dementia have to decide between tube feeding and hand feeding when persistent eating problems arise. This decision can be difficult for Chinese American dementia careg...

Austin, MN60 participantsYaolin Pei

View Study Details

NCT07391605Recruiting

Descartes-08 in Autoantibody Myositis

This is a randomized, double-blind, placebo-controlled phase 2 study to evaluate the efficacy, safety and tolerability of an autologous T-cells expressing a chimeric antigen receptor (CAR) directed to...

Austin, MN60 participantsCartesian Therapeutics

View Study Details

About Myalgic Encephalomyelitis Clinical Trials in Austin

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 8 myalgic encephalomyelitis clinical trials recruiting participants in Austin, MN. These studies are seeking a combined 1,113 participants. Research is being sponsored by Innovent Biologics (Suzhou) Co. Ltd., Aulos Bioscience, Inc., Pliant Therapeutics, Inc. and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Austin — FAQ

Are there myalgic encephalomyelitis clinical trials in Austin?

Yes, there are 8 myalgic encephalomyelitis clinical trials currently recruiting in Austin, MN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Austin?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Austin research site will contact you about next steps.

Are clinical trials in Austin free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Austin studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 8 active trials in Austin are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 13, 2026 from ClinicalTrials.gov